A new drug called AF-130 has been developed that offers “two-for-one” treatment of heart failure and sleep apnea by targeting the nervous activity that drives both. newatlas.com Submitted by chrisdh79 t3_127m0gx on March 31, 2023 at 1:46 PM in science 44 comments 702
50StatePiss t1_jef8vji wrote on March 31, 2023 at 4:08 PM I look forward to not being able to afford this for 20 years until it comes out of patent. Permalink 21
Viewing a single comment thread. View all comments